Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$1.10 CAD
Change Today -0.05 / -4.35%
Volume 4.3K
As of 2:29 PM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tony Matzouranis

Vice President of Business Development, BELLUS Health Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Tony Matzouranis has been the Vice President of Business Development at BELLUS Health Inc. since February 21, 2012. Mr. Matzouranis joined Bellus in 2010 and oversees BELLUS Health ’s licensing and business development activities. He served as a Senior Director, Business Development of BELLUS Health Inc. from March 2010 to February 21, 2012. He has over 13 years of experience in structuring and building successful partnerships via in / out-licensing, mergers and ...

Read Full Background

Corporate Headquarters*

275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7


Phone: 450-680-4500
Fax: 450-680-4501

Board Members Memberships*

There is no Board Members Memberships data available.


Master's Degree
Universite Du Quebec

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$176,750

Stock Options*

All Other CompensationC$20,838
Total Value of OptionsC$360,000
Total Number of Options400,000

Total Compensation*

Total Annual Cash CompensationC$226,752
Total Short Term CompensationC$176,750
Other Long Term CompensationC$20,838
Total Calculated CompensationC$226,752
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLU:CN C$1.10 CAD -0.05


Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
Elliot Goldstein M.D.Chief Executive Officer, President, Director, Member of Corporate Governance and Nominating Committee and Member of Compensation Committee
Amorfix Life Sciences Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BELLUS HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at